A股異動 | 大連聖亞(600593.SH)跌停 賣52只企鵝創收2212萬 再遭上交所嚴厲問詢
格隆匯7月8日丨通過出售52只企鵝創收2212萬元的大連聖亞(600593.SH),昨日再遭上交所嚴厲問詢,大連聖亞今天盤中跳水跌停,報17.82元創近三年半新低,最新總市值23億元。

問詢函要求公司和年審會計事務所進一步核實並補充披露針對企鵝交易的真實性等現場檢查未提供的材料清單、年審會計師審計執業問題等會計處理和信息披露問題。
6月11日,上交所曾向大連聖亞發出工作函,要求公司核實年報相關信息披露不準確、不完整的情況,但大連聖亞至今未落實相關整改並披露。這是自4月30日以來,上交所向大連聖亞發出了第4份問詢函。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.